Ritapiram

利他匹仑

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameRitapiram
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstaglandin D2 receptor 2 antagonists
TargetsProstaglandin D2 receptor 2
Therapy Area/IndicationsRhinitis, AllergicAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesHec Pharm Co Ltd
Active IndicationsRhinitis, Allergic
Inactive IndicationsAsthma

Other Information

ATC CodeN/A
Related LinksN/A